Open AccessTreatment challenges and survival analysis of human epidermal growth factor receptor 2-positive breast cancer in real world
Author(s) -
Praveen Adusumilli,
Meher Lakshmi Konatam,
Sadashivudu Gundeti,
Stalin Bala,
Lakshmi Srinivas Maddali
Publication year - 2017
Publication title -
indian journal of medical and paediatric oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 22
eISSN - 0975-2129
pISSN - 0971-5851
DOI - 10.4103/0971-5851.203511
Subject(s) - medicine , human epidermal growth factor receptor 2 , oncology , breast cancer , cancer , epidermal growth factor receptor , epidermal growth factor , receptor , cancer research
Advent of trastuzumab has brought tremendous changes in the survival of human epidermal growth factor receptor 2 (Her2)-positive breast cancer patients. Despite the availability of the drug, it is still out of reach for many patients. There is very limited real world data regarding treatment challenges and survival analysis of these patients.